'Tis the season for burying the hatchet. A settlement last month by R2 and iCAD over patent infringement was followed Sept. 19 by the announcement that Nomos and Zmed had settled their differences. The radiotherapy companies put to rest two pending
'Tis the season for burying the hatchet. A settlement last month by R2 and iCAD over patent infringement was followed Sept. 19 by the announcement that Nomos and Zmed had settled their differences. The radiotherapy companies put to rest two pending patent infringement suits relating to patient positioning and target verification products, namely Nomos BAT and BAT SXi products and Zmed's SonArray product. The agreement resolves all claims and provides cross-licensing of patent rights.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.